Saikosaponin A Inhibits Breast Cancer by Regulating Th1/Th2 Balance
Authors:
Open Access
- 4 June 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 624
Abstract
Saikosaponin A (SSa) is isolated from the dried root of Radix Bupleuri, an herb widely used in traditional Chinese medicine, exerting antitumor activities. The T helper cell type 1(Th1)/Th2 balance is associated with antitumor immunity in breast cancer. The present study aimed to investigate the effects of SSa on Th1/Th2 balance in breast cancer and to explore the underlying mechanisms. Breast cancer in rats was induced by intragastrical administration of 7,12-dimethyl-benz[a] anthracene once (100 mg/kg). At d91, the rats suffering from tumors were randomly divided into three groups and treated with vehicle solution (control group), tamoxifen (TAM group), and SSa (SSa group) daily for 56 days, respectively. The tumor volume reduction ratio and tumor cell proliferation were detected to assess the antitumor effect of SSa. The positive staining numbers of CD8+ and CD4+ T cells infiltrated in breast tumors were measured by immunohistochemistry to evaluate the antitumor immunity of SSa. Cytokine levels in serum secreted by Th1 cells [interferon gamma (IFN-γ), interleukin (IL)-12] and Th2 cells (IL-4, IL-10) were detected to evaluate Th1/Th2 balance. The related molecules of IL-12/signal transducers and activators of transcription 4 (STAT4) pathway were detected by immunohistochemistry staining, RT-PCR, and Western blot to explore the mechanisms of SSa. The results showed that, compared with the control group, SSa significantly inhibited tumor growth and tumor cell proliferation. SSa enhanced antitumor immunity, which was demonstrated as increased CD8+ T cells and CD4+ T cells infiltrated in tumors. SSa shifted Th1/Th2 balance toward Th1, which was confirmed as increased serum IFN-γ and IL-12 levels, while decreased serum IL-4 and IL-10 levels. SSa increased IL-12, IL-12 receptor, and phosphorylated STAT4 expressions to promote Th1 differentiation. In conclusion, the present work suggested that SSa could inhibit breast cancer growth by shifting Th1/Th2 balance toward Th1. The underlying mechanism may involve activation of the IL-12/STAT4 pathway that induced Th1 differentiation.Keywords
Funding Information
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
This publication has 25 references indexed in Scilit:
- Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?Laboratory Investigation, 2018
- Understanding the tumor immune microenvironment (TIME) for effective therapyNature Medicine, 2018
- Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practiceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2017
- Immune Escape in Breast Cancer DuringIn Situto Invasive Carcinoma TransitionCancer Discovery, 2017
- Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancerCancer Treatment Reviews, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Relevance of tumor-infiltrating lymphocytes in breast cancerBMC Medicine, 2015
- Innate and adaptive immune cells in the tumor microenvironmentNature Immunology, 2013
- Sustained IL-12 Signaling Is Required for Th1 DevelopmentThe Journal of Immunology, 2004
- Saikosaponin-A Induces Apoptotic Mechanism in Human Breast MDA-MB-231 and MCF-7 Cancer CellsThe American Journal of Chinese Medicine, 2003